Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix

Published:2003-03-19 Issue:2 Volume:52A Page:101-109
ISSN:0196-4763
Container-title:Cytometry
language:en
Short-container-title:Cytometry

Author:

Vugmeyster Yulia,Howell Kathy,Bakshl Anahid,Flores Clarissa,Canova-Davis Eleanor

Publisher

Wiley

Subject

Cell Biology,Endocrinology,Hematology,Biophysics,Pathology and Forensic Medicine

Reference25 articles.

1. Upgrading of Flow Cytometric Analysis for Absolute Counts, Cytokines and Other Antigenic Molecules of Cynomolgus Monkeys(Macaca fascicularis) by Using Anti-Human Cross-Reactive Antibodies.

2. Peripheral blood CD4+CD8+ lymphocytes in cynomolgus monkeys are of resting memory T lineage

3. Comparative analysis of natural killer cell activity, lymphoproliferation and lymphocyte surface antigen expression in nonhuman primates housed at the CIRMF Primate Center, Gabon

4. CD40L Pathway Blockade as an Approach to Immunotherapy

5. Clinical applications of anti-CD20 antibodies

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marginal zone B cells are required for optimal humoral responses to allograft;American Journal of Transplantation;2024-09

2. Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study;Frontiers in Pharmacology;2024-01-09

3. Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases;British Journal of Clinical Pharmacology;2019-06-20

4. Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing;Scientific Reports;2018-01-09

5. A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells;Molecular Cancer Therapeutics;2016-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3